Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2009

Mar 23, 2009

34519_dirs_2009-03-23_a189bdbf-9fe8-4933-9d2f-b32cc5b62e05.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2009-03-19

Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-03-19 Common stock, par value $0.10 per share P 400 $1.81 Acquired 440402 Direct

Footnotes

F1: This figure includes 185,173 of common stock, held by Arterio, Inc., a corporation owned soley by Mr. Rothschild.